Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001247424-07-000002
Filing Date
2007-06-07
Accepted
2007-06-07 19:15:21
Documents
1
Period of Report
2007-06-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3488
  Complete submission text file 0001247424-07-000002.txt   5306
Mailing Address C/O CELLEGY PHARMACEUTICALS INC 349 OYSTER POINT BLVD #200 S. SAN FRANCISCO CA 94080
Business Address 6506162200
CHANDLER JOHN J (Reporting) CIK: 0001247424 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33516 | Film No.: 07907929

Mailing Address 18 FARM LANE HILLSBOROUGH CA 94010
Business Address 18 FARM LANE HILLSBOROUGH CA 94010 650-344-3029
APEX BIOVENTURES ACQUISITION CORP (Issuer) CIK: 0001368613 (see all company filings)

EIN.: 204997725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks